{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:00:24Z","timestamp":1774566024976,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1378\/chest.122.2.618","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"618-623","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic Ratio of Hydrofluoroalkane and Chlorofluorocarbon Formulations of Fluticasone Propionate"],"prefix":"10.1016","volume":"122","author":[{"given":"Stephen J.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda C.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika J.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme P.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl B","key":"10.1378\/chest.122.2.618_bib1","first-page":"S29","article-title":"Clinical efficacy and safety of fluticasone propionate 250 microgram twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma: French Study Group","volume":"94","author":"Tonnel","year":"2000","journal-title":"Respir Med"},{"issue":"Suppl B","key":"10.1378\/chest.122.2.618_bib2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0954-6111(00)90152-5","article-title":"Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma: International study group","volume":"94","author":"Perruchoud","year":"2000","journal-title":"Respir Med"},{"issue":"Suppl B","key":"10.1378\/chest.122.2.618_bib3","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0954-6111(00)90153-7","article-title":"Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma: U.K. Study Group","volume":"94","author":"Ayres","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.618_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.323.7307.253","article-title":"Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis","volume":"323","author":"Holt","year":"2001","journal-title":"BMJ"},{"issue":"Suppl B","key":"10.1378\/chest.122.2.618_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0954-6111(00)90147-1","article-title":"Pharmaceutical transition to non-CFC pressurized metered dose inhalers","volume":"94","author":"Cripps","year":"2000","journal-title":"Respir Med"},{"issue":"Suppl B","key":"10.1378\/chest.122.2.618_bib6","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0954-6111(00)90148-3","article-title":"Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs","volume":"94","author":"Kunka","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.618_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-200023010-00002","article-title":"Safety of inhaled and intranasal corticosteroids: lessons for the new millennium","volume":"23","author":"Lipworth","year":"2000","journal-title":"Drug Safety"},{"key":"10.1378\/chest.122.2.618_bib8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(99)03581-3","article-title":"Differences in lung bioavailability between different propellants for fluticasone propionate","volume":"354","author":"Wilson","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.122.2.618_bib9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.153.6.8665033","article-title":"Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract","volume":"153","author":"Kharitonov","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.2.618_bib10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/ajrccm\/136.5.1285","volume":"136","author":"Standardization of spirometry, 1987 update: statement of the American Thoracic Society","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.122.2.618_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thx.48.3.239","article-title":"Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response","volume":"48","author":"Beach","year":"1993","journal-title":"Thorax"},{"key":"10.1378\/chest.122.2.618_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"key":"10.1378\/chest.122.2.618_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(99)00435-0","article-title":"Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma","volume":"108","author":"Wilson","year":"2000","journal-title":"Am J Med"},{"key":"10.1378\/chest.122.2.618_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/thx.54.2.108","article-title":"Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma","volume":"54","author":"Jatakanon","year":"1999","journal-title":"Thorax"},{"key":"10.1378\/chest.122.2.618_bib15","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1164\/ajrccm.162.6.9912072","article-title":"Therapeutic ratio of inhaled corticosteroids in adult asthma: a dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function","volume":"162","author":"Nielsen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.2.618_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0149-2918(96)80214-1","article-title":"Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study","volume":"18","author":"Wolfe","year":"1996","journal-title":"Clin Ther"},{"key":"10.1378\/chest.122.2.618_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.122.2.618_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/thx.54.1.20","article-title":"24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids","volume":"54","author":"Wilson","year":"1999","journal-title":"Thorax"},{"key":"10.1378\/chest.122.2.618_bib19","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/thx.50.12.1280","article-title":"Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens","volume":"50","author":"McIntyre","year":"1995","journal-title":"Thorax"},{"issue":"Suppl 1","key":"10.1378\/chest.122.2.618_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003088-200039001-00006","article-title":"Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma","volume":"39","author":"Daley-Yates","year":"2000","journal-title":"Clin Pharmacokinetics"},{"key":"10.1378\/chest.122.2.618_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/thorax.56.3.186","article-title":"Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects","volume":"56","author":"Harrison","year":"2001","journal-title":"Thorax"},{"key":"10.1378\/chest.122.2.618_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(00)02581-2","article-title":"Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study","volume":"356","author":"Brutsche","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.122.2.618_bib23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1378\/chest.116.4.931","article-title":"Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate","volume":"116","author":"Weiner","year":"1999","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215513974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215513974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:30:30Z","timestamp":1553113830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215513974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0012369215513974"],"URL":"https:\/\/doi.org\/10.1378\/chest.122.2.618","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}